Header Logo

Connection

Michael Kiernan to Cyclic Nucleotide Phosphodiesterases, Type 5

This is a "connection" page, showing publications Michael Kiernan has written about Cyclic Nucleotide Phosphodiesterases, Type 5.
  1. Grandin EW, Gulati G, Nunez JI, Kennedy K, Rame JE, Atluri P, Pagani FD, Kirklin JK, Kormos RL, Teuteberg J, Kiernan MS. Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis. Circ Heart Fail. 2022 04; 15(4):e008613.
    View in: PubMed
    Score: 0.198
  2. Gulati G, Kiernan MS. Phosphodiesterase-5 Inhibitor Therapy for Left Ventricular Assist Device Patients: More Data, More Questions. J Am Heart Assoc. 2020 07 21; 9(14):e017585.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.